Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FCMZL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,786
Award facts
- Contract value 100% obligated
- $3,785.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a firm fixed-price delivery order valued at $3,785.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on September 4, 2025, covers the supply of Nucala 100 mg/mL auto-injector units and is scheduled for completion by September 5, 2025. The award carries no set-aside designation, and DMS Pharmaceutical Group is performing the work at its Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a comprehensive pharmaceutical supply agreement valued at $499,999,999 and valid through November 2026. The IDC enables the agency to procure a broad range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. As a established federal supplier since 2001, DMS Pharmaceutical Group serves as a key provider in the military healthcare supply chain, and this delivery order exemplifies the routine pharmaceutical procurement operations conducted under its master contract vehicle.
Quick answers
Who was awarded contract SPE2DB25FCMZL?
SPE2DB25FCMZL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FCMZL worth?
The government has obligated $3,786 on SPE2DB25FCMZL.
Is contract SPE2DB25FCMZL an order under another contract?
Yes. SPE2DB25FCMZL is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMZL competed?
The extent of competition for SPE2DB25FCMZL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award